Legal Representation
Attorney
Bruce W. Longbottom
USPTO Deadlines
Next Deadline
44 days remaining
Statement of Use Due - Extension 1 Granted
Due Date
September 17, 2025
Extension Available
Until September 17, 2025
Application History
12 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Feb 5, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Feb 4, 2025 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
Feb 4, 2025 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
Feb 4, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Sep 17, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
Jul 23, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Jul 23, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Jul 3, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Jun 20, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Jun 20, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Mar 4, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Dec 7, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, hearing loss, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases
Additional Information
Translation
The wording "ZONKAYRAS" has no meaning in a foreign language.
Classification
International Classes
005